OPFOLDA DIN 02556812
Status: Marketed
Holder: AMICUS THERAPEUTICS CANADA INC.
Available to quote
Health Canada record
| Active ingredient(s) | MIGLUSTAT 65 MG |
|---|
| Dosage form | Capsule |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | A16AX06 MIGLUSTAT |
|---|
| Original market date | 05-Dec-2025 |
|---|
| Current status date | 05-Dec-2025 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MIGLUSTAT
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02456257 | SANDOZ MIGLUSTAT | SANDOZ CANADA INCORPORATED | Capsule | MIGLUSTAT 100 MG | Marketed |
| 02250519 | ZAVESCA | JANSSEN INC | Capsule | MIGLUSTAT 100 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 35159 | 2025-04-10 | New Drug Submission (NDS) | |
International API supply for MIGLUSTAT
4 active FDA Drug Master Files.
Request a quote for OPFOLDA
How to read a Canadian DIN record